跳至主要内容
临床试验/ACTRN12622000862741
ACTRN12622000862741招募中3 期

Managing Delirium with FLUvoxamine treatment in Non-Cardiac Surgical patients: a feasibility trial

Royal Prince Alfred Hosptial0 个研究点目标入组 46 人开始时间: 2022年6月17日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
60 Years 至 o limit(—)
性别
All

入选标准

  • Elective non-cardiac, non-intracranial surgical patients who are older than 60 years old with an expected length of hospital stay of >2 days

排除标准

  • Non-english speaking
  • Participants who may have received an investigational new drug within the last 7 days/weeks.
  • Participants who lack capacity to provide informed consent.
  • Participants with prior known intolerance/allergy to SSRIs or fluvoxamine.
  • Planned postoperative ventilation
  • Patients on medications that interact with fluvoxamine: hepatic metabolism by CYP1A2 (theophylline, clozapine, tizadine, olanzapine), metabolism inhibited by fluvoxamine (diazepam, alprazolam, phenytoin), sigma-1
  • agonists/antagonists (donepezil, sertraline), risk of serotonin syndrome (St John’s Wort, selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs)

研究者

发起方
Royal Prince Alfred Hosptial

相似试验